NKG2D initiates caspase-mediated CD3zeta degradation and lymphocyte receptor impairments associated with human cancer and autoimmune disease. - Wikidata - awgldk - TriplyDB

NKG2D initiates caspase-mediated CD3zeta degradation and lymphocyte receptor impairments associated with human cancer and autoimmune disease.

NKG2D initiates caspase-mediated CD3zeta degradation and lymphocyte receptor impairments associated with human cancer and autoimmune disease.

http://www.wikidata.org/entity/Q42628431

about

Functionally Diverse NK-Like T Cells Are Effectors and Predictors of Successful Aging NKG2D Ligands in Tumor Immunity: Two Sides of a Coin MHC class I chain-related protein A and B (MICA and MICB) are predominantly expressed intracellularly in tumour and normal tissue.Control of Tumor Initiation by NKG2D Naturally Expressed on Ovarian Cancer Cells.Antibody-mediated neutralization of soluble MIC significantly enhances CTLA4 blockade therapy.Natural killer (NK) cell profiles in blood and tumour in women with large and locally advanced breast cancer (LLABC) and their contribution to a pathological complete response (PCR) in the tumour following neoadjuvant chemotherapy (NAC): differentia Immunobiology and conflicting roles of the human NKG2D lymphocyte receptor and its ligands in cancer.Progressive natural killer cell dysfunction associated with alterations in subset proportions and receptor expression in soft-tissue sarcoma patients.Generation of soluble NKG2D ligands: proteolytic cleavage, exosome secretion and functional implications.IL-17 producing T cells in celiac disease: angels or devils?Extracellular 2'5'-oligoadenylate synthetase 2 mediates T-cell receptor CD3-ζ chain down-regulation via caspase-3 activation in oral cancer.Acute myeloid leukemia impairs natural killer cells through the formation of a deficient cytotoxic immunological synapse.c-Cbl regulates MICA- but not ULBP2-induced NKG2D down-modulation in human NK cells.Antibody-dependent cell lysis by NK cells is preserved after sarcoma-induced inhibition of NK cell cytotoxicity.Regulation of NKG2D-Dependent NK Cell Functions: The Yin and the Yang of Receptor Endocytosis.Neuropeptide Levels as well as Neprilysin Activity Decrease in Renal Cell Carcinoma.Chronic NKG2D Engagement In Vivo Differentially Impacts NK Cell Responsiveness by Activating NK Receptors.Downregulation of CD3ζ in NK Cells from Systemic Lupus Erythematosus Patients Confers a Proinflammatory Phenotype.NKG2D: A Master Regulator of Immune Cell Responsiveness.NKG2D Ligands-Critical Targets for Cancer Immune Escape and Therapy

P2860

Q28077020-23D8A417-31DA-4C0F-AE74-C48D6F728D61 Q28083832-CD052730-76A5-4495-A41B-842E408466EF Q33639723-952C10E1-473F-4EA6-AE5A-C3A05304B91F Q33676231-9A4A309D-A115-4815-95FE-4CECCD49FFB9 Q33699687-D3AE6793-D4B8-49F6-9C5C-24A03F6C3F5F Q35743162-AF73E708-71C9-4AB4-A6FC-6E8DF2FB041C Q37077413-EC524C32-E27F-489C-AC87-45569852F06F Q37222064-607DF971-453B-4D32-BD66-0003A7B219C7 Q38107250-121DE11A-0A40-40EF-91A4-27A30452C226 Q38138107-1227897B-7CCB-4A3D-A891-656B99921668 Q38817649-E6624854-1267-4A79-9B6A-1BF054558DB7 Q38973867-7C50C0EF-F8F0-4CF2-A275-59F32DE2C24D Q38993228-63D0B1AC-46F5-45F0-93BF-6DDFA8B2298B Q39159252-1080D6A0-8DCC-4074-9497-8E8076A4F9C6 Q40098295-B81F1356-BFE3-4CB1-AFFF-C9C6EFBE7A7C Q41826076-EB63832C-8B7F-4CF9-8A24-F0E19704CB58 Q47114951-51A24FBC-3EC2-4CED-9E87-474E94262CA8 Q52722794-0D584D7C-199E-4148-AEE7-ACE511C580B8 Q55216305-ED6AD916-2CC9-4326-8A01-A36A384AE194 Q58750637-E80BA1EA-C2D0-47BE-AD58-5F2903510A44

P2860

NKG2D initiates caspase-mediated CD3zeta degradation and lymphocyte receptor impairments associated with human cancer and autoimmune disease.

http://www.wikidata.org/entity/Q42628431

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

NKG2D initiates caspase-mediat ...... cancer and autoimmune disease.

@en

NKG2D initiates caspase-mediat ...... cancer and autoimmune disease.

@nl

type

label

NKG2D initiates caspase-mediat ...... cancer and autoimmune disease.

@en

NKG2D initiates caspase-mediat ...... cancer and autoimmune disease.

@nl

prefLabel

NKG2D initiates caspase-mediat ...... cancer and autoimmune disease.

@en

NKG2D initiates caspase-mediat ...... cancer and autoimmune disease.

@nl

P1433

Q42628431-C59BFDE8-1E57-47F3-B34B-2DB30CC72FB9

P1476

Q42628431-8A565E19-36CC-4C1F-887F-C652582C40BD

P2093

Q42628431-0312F47D-E374-470D-8351-470073AFEB43

Q42628431-200DC672-00E8-4B68-9B00-F91E1CA04349

Q42628431-262EE858-4B66-4B60-A915-D9D3004C369C

Q42628431-42570F9F-B89A-4DF8-A6B5-06D551F0237D

Q42628431-59518E74-7514-428C-B3BE-2828CC55AD4E

Q42628431-7E8BDCB3-4E00-4FAE-9C67-4269E407BED9

Q42628431-B18521CC-04FC-4C9F-A63F-677D0DD203BB

Q42628431-E1060BF1-CE12-4A6A-855F-811FB54D2301

Q42628431-F016E62F-5305-4E51-B5D0-5D0A26AC92B8

P2860

Q42628431-02A5D425-AD20-4F4D-A1DC-253A604ABEE7

Q42628431-04E2FDFA-84E3-4DD6-A4B6-146D4583CFDF

Q42628431-076982AB-04B3-432A-8A96-F02D570138AE

Q42628431-08448C5A-AEEA-439B-AEDB-7E85F983762D

Q42628431-0E43E408-DA67-471A-AF7C-BBAB6E7A1AD7

Q42628431-0E89D6A1-295D-4B24-8CF1-6D9E48DD50F9

Q42628431-16C71DD7-80FC-426F-A009-FFE40817C2F1

Q42628431-17BCDDF9-2478-4731-8951-EDC667E982D6

Q42628431-278F078A-4E09-4AC7-A3F8-58DBA7FF6B6B

Q42628431-2B45AB81-EF68-472F-A16D-E2F8F0FB6626

P304

Q42628431-4778FE2A-79DE-44F8-8952-7637C2B0439F

P31

Q42628431-21AECFEA-D82E-490F-9491-99103B029478

P356

Q42628431-50F8EA88-F335-498D-B208-B543AA616D54

P407

Q42628431-32921E03-5B55-4ED6-A540-9CDC21F4D426

P433

Q42628431-61AB4D5A-2255-4F01-9AF9-E18F2461539E

P478

Q42628431-67A323EC-C82F-4C41-8CEF-3DD340465081

P577

Q42628431-E0255D40-408B-4D4F-B5B9-1C65C00DC458

P5875

Q42628431-7D255B56-3DB4-4E8A-AF4F-F752D8EEEB59

P698

Q42628431-0FC1F0A2-4496-4784-9878-2095CE315B0F

P932

Q42628431-B5944B3C-7EA3-4FE2-84BB-752A04E97A80

P356

JIMMUNOL.1002092

P1433

Journal of Immunology

P1476

NKG2D initiates caspase-mediat ...... cancer and autoimmune disease.

@en

P2093

Anne M Stevens

http://www.w3.org/2001/XMLSchema#string

Bana Jabri

http://www.w3.org/2001/XMLSchema#string

Cassian Yee

http://www.w3.org/2001/XMLSchema#string

Cezary Ciszewski

http://www.w3.org/2001/XMLSchema#string

Hideki Nakakuma

http://www.w3.org/2001/XMLSchema#string

Nobuyoshi Hanaoka

http://www.w3.org/2001/XMLSchema#string

Thomas Spies

http://www.w3.org/2001/XMLSchema#string

Veronika Groh

http://www.w3.org/2001/XMLSchema#string

Zhenpeng Dai

http://www.w3.org/2001/XMLSchema#string

P2860

Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB

Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA

An activating immunoreceptor complex formed by NKG2D and DAP10

Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells

Interactions of human NKG2D with its ligands MICA, MICB, and homologs of the mouse RAE-1 protein family

Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta T cells

Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium

2B4: an NK cell activating receptor with unique specificity and signal transduction mechanism

UL16-binding proteins, novel MHC class I-related proteins, bind to NKG2D and activate multiple signaling pathways in primary NK cells

Ovarian carcinoma expresses the NKG2D ligand Letal and promotes the survival and expansion of CD28- antitumor T cells

P304

5732-5742

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4049/JIMMUNOL.1002092

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

185

http://www.w3.org/2001/XMLSchema#string

P577

2010-10-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47357619

http://www.w3.org/2001/XMLSchema#string

P698

20926796

http://www.w3.org/2001/XMLSchema#string

P932

3044081

http://www.w3.org/2001/XMLSchema#string